Skip to content

CHRIS PHARMA WORKS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CHRIS PHARMA WORKS

BE 0554.695.686
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€13,242
2024 · €14,363-€1,121
Equity
-€273,992
2024 · -€287,234+€13,242
Cash
€3,485
2024 · €1,097+€2,389
Balance sheet total
€24,086
2024 · €25,209-€1,122

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€4,146

    down €4,146 (-22.8%), from €18,176 to €14,030

    of which Furniture and vehicles: -€5,705

  • Cash +€2,389

    up €2,389 (+218%), from €1,097 to €3,485

    mainly Net result for the year (+€13,242) and Depreciation (+€5,794)

  • Receivables within one year +€1,893

    up €1,893 (+43.1%), from €4,390 to €6,283

  • Deferred charges and accrued income -€1,259

    down €1,259 (-87.5%), from €1,438 to €179

Equity and liabilities
  • Debts after one year -€14,853

    down €14,853 (-18.5%), from €80,140 to €65,287

    of which Financial debts: -€8,853

  • Profit (loss) carried forward +€13,242

    up €13,242 (+4.3%), from -€305,834 to -€292,592

  • Trade debts +€686

    up €686 (+29.1%), from €2,358 to €3,044

  • Tax, wage and social debts -€419

    down €419 (-20.9%), from €2,005 to €1,586

Income statement
  • Gross operating margin -€2,060

    down €2,060 (-7.9%), from €26,042 to €23,982

  • Other operating charges -€1,471

    down €1,471 (-42.1%), from €3,493 to €2,022

  • Depreciation +€1,149

    up €1,149 (+24.7%), from €4,645 to €5,794

  • Financial charges -€608

    down €608 (-18.0%), from €3,367 to €2,759

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €14,363
Gross operating margin -€2,060
Depreciation -€1,149
Other operating charges +€1,471
Financial income -€0
Financial charges +€608
Taxes +€9
Result 2025 €13,242
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€18,890
Investment -€1,649
Financing -€14,853
Cash 2024 €1,097
Net result for the year +€13,242
Depreciation +€5,794
Receivables within one year -€1,893
Deferred charges and accrued income +€1,259
Trade debts +€686
Tax, wage and social debts -€419
Other debts +€222
Investment in fixed assets (net) -€1,649
Debts after one year -€14,853
Cash 2025 €3,485
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €25,209 €24,086 -€1,122 -4.5%
Fixed assets 21/28 €18,284 €14,139 -€4,146 -22.7%
Tangible fixed assets 22/27 €18,176 €14,030 -€4,146 -22.8%
Plant, machinery and equipment 23 - €1,560 +€1,560
Furniture and vehicles 24 €18,176 €12,471 -€5,705 -31.4%
Financial fixed assets 28 €108 €108 = 0.0%
Current assets 29/58 €6,924 €9,948 +€3,023 +43.7%
Amounts receivable within one year 40/41 €4,390 €6,283 +€1,893 +43.1%
Trade receivables 40 €4,390 €6,283 +€1,893 +43.1%
Cash at bank and in hand 54/58 €1,097 €3,485 +€2,389 +218%
Deferred charges and accrued income 490/1 €1,438 €179 -€1,259 -87.5%
Total equity and liabilities 10/49 €25,209 €24,086 -€1,122 -4.5%
Equity 10/15 -€287,234 -€273,992 +€13,242 +4.6%
Contributions 10/11 €18,600 €18,600 = 0.0%
Profit (loss) carried forward 14 -€305,834 -€292,592 +€13,242 +4.3%
Amounts payable 17/49 €312,442 €298,078 -€14,364 -4.6%
Amounts payable after more than one year 17 €80,140 €65,287 -€14,853 -18.5%
Financial debts 170/4 €66,400 €57,547 -€8,853 -13.3%
Other amounts payable 178/9 €13,740 €7,740 -€6,000 -43.7%
Amounts payable within one year 42/48 €232,302 €232,791 +€489 +0.2%
Current portion of amounts payable after more than one year 42 €6,000 €6,000 = 0.0%
Trade debts 44 €2,358 €3,044 +€686 +29.1%
Suppliers 440/4 €2,358 €3,044 +€686 +29.1%
Taxes, remuneration and social security 45 €2,005 €1,586 -€419 -20.9%
Taxes 450/3 €2,005 €1,586 -€419 -20.9%
Other amounts payable 47/48 €221,939 €222,161 +€222 +0.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,645 €5,794 +€1,149 +24.7%
Other operating charges 640/8 €3,493 €2,022 -€1,471 -42.1%
Gross operating margin 9900 €26,042 €23,982 -€2,060 -7.9%
Operating profit (loss) 9901 €17,904 €16,166 -€1,738 -9.7%
Financial income 75/76B €0 - -€0
Recurring financial income 75 €0 - -€0
Financial charges 65/66B €3,367 €2,759 -€608 -18.0%
Recurring financial charges 65 €3,367 €2,759 -€608 -18.0%
Profit (loss) for the period before taxes 9903 €14,537 €13,407 -€1,130 -7.8%
Income taxes 67/77 €174 €165 -€9 -5.2%
Profit (loss) for the period 9904 €14,363 €13,242 -€1,121 -7.8%
Profit (loss) for the period to be appropriated 9905 €14,363 €13,242 -€1,121 -7.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.